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Introduction
 Cancer of the oral cavity is one of the most com-
mon cancers in the world and is a major cause of 
morbidity and mortality.  Developing countries 
have the world's highest reported incidence of oral 
cancer.  Even with the advancement of medical 
technologies and prognostic aids, oral cancer in 
the Indian subcontinent accounts for approxi-
mately 40% of all malignant tumors, with an inci-
dence of about 56,000 cases per year.
　Identiﬁcation of high risk groups with respect to 
recurrence or rapid development of disease is 
important in the development of therapies for oral 
cancer.  Assessment of the size of the primary 
lesion, the number of regional lymph nodes show-
ing metastasis and the presence of distant metas-
tasis are widely used to deﬁne the extent of tumor 
load and determine treatment options for patients 
with intra-oral squamous cell carcinoma.  The 
TNM staging system is the conventional method 
for making treatment decisions.  However, one of 
the criticisms of the TNM staging is that it ignores 
individual histological characteristics of tumors, 
and it has been proposed that a combined assess-
ment of histological grading as well as clinical 
staging might provide a more precise measure for 
predicting the outcome of neoplasms and deciding 
the optimal treatment for each patient.  Although 
there are several different approaches for predict-
ing the prognosis of patients with oral cancer, 
none of them are completely satisfactory1, 2.
　The assessment of nuclear features is very 
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Abstract : In the present study, an objective and reproducible evaluation of mitotic activity and 
nuclear morphometric factors was attempted in 30 patients of oral squamous cell carcinoma with a 
view to predicting local relapse and survival.  Various nuclear parameters and volume-corrected 
mitotic index were calculated and compared with the recurrence and death of the study group (n = 
30).  Volume-corrected mitotic index (M/V index) was the single best prognosticator for recurrence 
of oral squamous cell carcinoma (p = 0.008 for recurrence ; p = 0.015 for death).  The combination of 
M/V and SD of nuclear area (forward stepwise regression) was a more efﬁcient and better predictor 
of survival (Log rank test, Kaplan-Meier's survival analysis ; χ2 = 17.46, p = 0.00001).  The present 
study proved the effectiveness of the M/V index in predicting the biological behavior and the out-
come of oral squamous cell carcinoma patients.
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important in the histological grading of oral 
squamous cell carcinoma.  The various morpho-
metric parameters studied for epithelial tumors 
are nuclear area, nuclear perimeter, nuclear shape 
factor, smallest and longest axes, nuclear size 
along with nuclear-cytoplasmic ratio and nucleo-
lar-nuclear ratio3.  The morphometry of epithelial 
tumor cells has been studied to examine its corre-
lation with the prognosis of various tumors of the 
breast, cervix, ovary and bladder4, 5.
　Haapasalo et al.6 developed the volume-cor-
rected mitotic index which was shown to be supe-
rior to the clinical stage and histologic grade in 
predicting the outcome of ovarian cancer.  The efﬁ-
ciency of this index was tested in oral cancer by 
Imai et al.1
　This study was undertaken to assess the prog-
nostic correlation of the various morphometric 
nuclear parameters―nuclear-cytoplasmic ratio (N/
C ratio), nuclear-nucleolar ratio, mitotic activity 
index (MAI) and volume-corrected mitotic activity 
(M/V index)―in oral squamous cell carcinoma.  An 
attempt was made to identify the single best prog-
nostic indicator as well as a combination of mor-
phometric parameters which can efﬁciently pre-
dict the outcome of the disease.
Materials and methods
1. Selection of patients
　The study group consisted of 30 patients with 
oral squamous cell carcinoma who were diagnosed, 
treated and followed from 1999 to 2004 at the 
Department of Oral and Maxillofacial Surgery, 
Manipal College of Dental Sciences, Mangalore. 
The clinical features are summarized in Table 1. 
Table 1　 Clinical features, staging and clinical outcome of the patients with 
primary oral squamous cell carcinoma
S No
Clinical
Parameters
Number of 
Cases
Percentage
1 Age
<60 15 50
≥ 60 15 50
2 Gender
Male 22 73.3
Female 8 26.7
3 Location 
Lip 1 3.3
Palate 2 6.7
Alveolus 8 26.7
Tongue 9 30.0
Buccal Mucosa 10 33.3
4
T Stage
T2 8 26.7
T3 9 30.0
T4 13 43.3
N Stage 
N0  6 20.0
N1 13 43.3
N2 11 36.7
Distant Metastasis
M0 29 96.7
M1 1 3.3
5 TNM Stage
II 3 10.0
III 13 43.3
IV 14 46.7
6 Recurrence
Recurred 15 50.0
Not Recurred 15 50.0
7 Clinical Outcome
Death  7 23.3
Alive 23 76.7
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Disease-free survival, overall survival, time of 
recurrence (if any), and mortality due to disease (if 
any) were chosen as prognosticators for the study. 
Disease-free survival is deﬁned as the time 
elapsed between the initial treatment of the tumor 
and the reappearance of a tumor of the same his-
tological type.  Overall survival is deﬁned as the 
time elapsed between initial diagnosis and death 
attributable to carcinoma.  Approval from the 
institutional ethical committee was obtained prior 
to the study.  The patients enrolled in the study 
satisﬁed the criteria of having undergone surgery 
as their initial and only mode of treatment ; with 
histologically clear excisional margins and a fol-
low-up for a minimum of 36 months or death, 
whichever was earlier.
2. Histomorphometric Parameters
　For the morphometric studies hematoxylin and 
eosin (H&E) stained parafﬁn-embedded sections 
(of ﬁve μm thickness) from the core of the tumor 
were used.  The histological malignancy grading 
and mode of invasion were judged according to the 
method proposed by Bryne et al.7
Parameter measurement
1. Mitotic activity index (MAI)4
　Mitotic activity index is expressed as the total 
number of sharply deﬁned mitoses per 10 high 
power ﬁelds at the invasive front.
　Accurate deﬁnition of mitotic ﬁgures was essen-
tial to the study.  Mitoses were counted at × 400 
magniﬁcation with a 40× objective (numerical 
aperture 0.65, ﬁeld diameter 450 μm).  Once 
focused, no further adjustments were made and 
structures that could be interpreted differently 
(such as artifacts) were not counted.  The exis-
tence of hairy protrusions or the presence of 
amphophillic cytoplasm was regarded as signs in 
favor of mitotic ﬁgures.  In contrast, the presence 
of a ﬁre cone ﬁgure, a dark line parallel with the 
margin or the presence of large, dark round spots 
were not regarded as mitotic ﬁgures.  If all these 
criteria did not allow a deﬁnite assignment, the 
ﬁgure under discussion was eliminated from the 
measurement.
2. Volume-corrected mitotic index (M/V index)6
　The M/V index (mitosis/volume index) was 
determined as described by Haapasalo et al.6 as 
M/V index = ∑MI / ∑Vν, where MI = number of 
mitotic ﬁgures in a randomly selected microscopic 
ﬁeld of neoplastic epithelium from the invasive 
front and Vν = volume fraction percent of neoplas-
tic epithelium assessed by the point-counting 
technique with a 1000-point square grid overlaid 
on the tumor image in each ﬁeld of vision.  In each 
ﬁeld, after counting the number of mitoses, points 
overlying the stroma and epithelium were counted 
and the percentage of points overlying the epithe-
lium was taken to be the volume percent of epithe-
lium.
3. Nuclear features4
　The nuclear features were measured using an 
eye-piece reticule, at 1000 × magniﬁcation (numeri-
cal aperture 1.25, oil immersion).  From 25 nuclei, 
the largest and the smallest diameters were mea-
sured (D = largest diameter of nucleus, d = small-
est diameter of nucleus).  Using these dimensions 
the area [ ], perimeter [ ], shape fac-
tor [ ] and nuclear size [ / ] were
assessed.  The shape factor is thus dimensionless, 
its value equaling 1.0 in round nuclei and being 
less than 1.0 in elliptical nuclei.  The mean and 
standard deviations were calculated for each of 
these variables and accordingly 12 nuclear param-
eters were used in the study.
4. Nuclear cytoplasmic ratio (N/C ratio)
　Usually, cytoplasmic boundaries are clearly visi-
ble in the sections and cytoplasmic area can be 
measured accurately.  If distinction was not possi-
ble, the cytoplasm of adjacent cells with the nuclei 
in focus was divided between the cells.  Thus, the 
mean nuclear-cytoplasmic (N/C) value per case 
could be reproduced with satisfactory accuracy.
5. Nucleolar-nuclear ratio
　Nucleolar area was measured in 25 nuclei at 
1000× magniﬁcation.  If more than one nucleolus 
was present in a nucleus, the largest was selected 
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for measurement.  The ratio was obtained by divid-
ing the measured nucleolar and nuclear areas.
Statistical analysis
　Four methods were used to study the prognostic 
value of observed and measured features using 
Statistical Package for Social Sciences (SPSS) ver-
sion 11.0.  First, the various morphometric param-
eters were compared with the recurrence and mor-
tality parameters by means of an independent 
Student's t test.  The sensitivity, speciﬁcity, posi-
tive predictive value (PPV), negative predictive 
value (NPV) and efﬁciency of each signiﬁcant 
parameter were evaluated to identify the single 
best prognosticator.  Cut-off values were arrived 
at for each parameter based on the efﬁciency 
(Tables 2 and 3).
　Second, a multivariate survival analysis was 
performed using Cox's regression model.  This 
survival analysis took into account the duration of 
disease-free survival from the time of surgical 
treatment to either recurrence or death.
　Thirdly, a discriminant analysis using stepwise 
logistic regression was performed to derive coefﬁ-
cients for each of the most important prognostica-
tors and to apply the parameters in combination 
in the regression model.
　Final analysis of survival was performed by 
Kaplan-Meier curves for each parameter sepa-
rately using log rank statistics.
　Deﬁnitions of efﬁciency, sensitivity and speciﬁc-
ity were taken from Galen and Gambino as fol-
lows :4
　Efﬁciency = 
　Sensitivity = 
　Speciﬁcity = 
where,
　TP = true positives, i.e., number of patients who 
died or had recurrence and are correctly predicted 
by a test,
　TN = true negatives, i.e., number of patients 
who survived and are correctly predicted by a test,
　FP = false positives, i.e., number of patients who 
survived and are incorrectly predicted by a test, 
and
　FN = false negatives, i.e., number of patients 
who died or developed recurrence and are incor-
rectly predicted by a test.
Results
　The study revealed that both nuclear and histo-
logic grades are signiﬁcant prognosticators of 
recurrence / death.  Of all the parameters associ-
ated with recurrence of the disease, only three 
parameters―invasive front grading (p = 0.008), 
mitotic activity index (p = 0.001) and volume-cor-
rected mitotic index (p = 0.008)―were signiﬁcant 
according to Student's t test (Table 2).  Of these 
three parameters, the M/V index showed the high-
est sensitivity, negative predictive value and efﬁ-
ciency (Table 2).
　The cut-off values of morphometric features 
demonstrated that a mitotic activity index exceed-
ing 15 mitoses per 10 high power ﬁelds was an 
ominous sign.  If the mean nuclear area exceeded 
80 μm2 and the standard deviation of nuclear 
area exceeded 30 μm2 the prognosis was consider-
ably worse.  The M/V values ranged from 0.23 to 
4.52 mitotic ﬁgures / mm2 with mean ± SD of 1.53 
± 1.18.  Keeping a cut-off of 1.5 for M/V, signiﬁ-
cant differences between the groups was observed 
with a p value of 0.015 (Table 3).
　Table 4 lists the parameters showing signiﬁcant 
differences for the event of death due to disease. 
Since some of these parameters contained redun-
dant information, a reduction to fewer parameters 
was desirable.  Thus, the ten signiﬁcant parame-
ters shown in Table 4 were used in the multivari-
ate survival analysis.  Both Cox regression analy-
sis and forward stepwise regression yielded 
coefﬁcients of two parameters : volume-corrected 
mitotic index and standard deviation of nuclear 
area.  The coefﬁcients of Cox regression analysis 
are given in Table 5, using which the formula for 
prognostic indicator of death (PIdeath) was derived :
　PIdeath = 0.01816(SD nuclear area) + 0.147(M/V)
　　　　  - 0.537
　Kaplan-Meier curves were plotted for the above 
three parameters (M/V index, SD nuclear area 
and PIdeath).  Figure 1 gives the two Kaplan-Meier 
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curves for the low PIdeath index ( < 0.4, n = 21 ;  
3-year survival 95.324%), and high PIdeath index 
patients ( > 0.4, n = 9 ;  3-year survival 33.33%). 
Survival analysis done for all parameters (deemed 
signiﬁcant by Student's t test) yielded signiﬁcant 
values for 7 of the 11 parameters (Table 6).  The 
highest χ2 value for a single parameter was 7.44 
for circular rate (shape factor), followed by SD of 
smaller diameter (χ2 value = 6.94).  In comparison 
with all the parameters, PIdeath had the highest χ2 
value of 17.46 accounting for the highest signiﬁ-
cance (Table 6).  The volume-corrected mitotic 
index was the single best predictor of progno-
sis (χ2 value of 4.46, p = 0.0347) (Table 6 and Fig-
ures 2 and 3).
Discussion
　Predicting the prognosis of oral squamous cell 
carcinoma (OSCC) greatly helps decide the treat-
ment modality.  Although there are various guides 
such as tumor size, lymph node metastasis, 
mitotic activity, mode of invasion and histological 
malignancy grading, their efﬁciency in predicting 
the disease outcome is not completely satisfactory. 
This is attributed to the variability and subjectiv-
ity present in the techniques of assessment. 
Quantitative methods are objective and reproduc-
ible, and their prognostic predictive value has 
been emphasized by various studies.
　Mitotic activity has been assessed by various 
techniques and has proven to be an efﬁcient prog-
nostic indicator of squamous cell carcinoma of var-
Table 2　Statistically signiﬁcant parameters predicting recurrence of tumor 
Factor Cut-off
Sensitivity 
(%)
Speciﬁcity 
(%) PPV 
(%) NPV (%) Efﬁciency (%)
Invasive front grading
 (p = 0.008) 10.0 80.0 66.6 70.6 76.9 73.33
Mitotic activity index
 (p = 0.001) 7.5 93.3 73.3 77.8 91.6 83.33
Volume-corrected mitotic 
index (p = 0.008) 1.0 100.0 73.3 91.6 100.0 86.87
Table 3　Comparison of different signiﬁcant parameters associated with prediction of death
Factor Cut-off
Sensitivity 
(%)
Speciﬁcity
(%) PPV 
(%) NPV (%) Efﬁciency (%)
Volume-corrected mitotic
index (M/V)  1.5 71.4 73.9 45.5 89.5 73.33
Nuclear area (μm2) 80.0 85.7 52.2 35.3 92.3 60.00
SD Nuclear area 30.0 71.4 65.2 38.5 88.2 66.67
Perimeter (μm) 438.0 85.7 60.9 40.0 93.3 66.67
SD perimeter 150.0 71.4 69.6 41.7 88.9 70.00
Circularity 0.65 85.7 69.6 46.2 94.1 70.00
Nuclear size 10.0 85.7 52.2 35.3 92.3 60.00
SD Nuclear size  1.7 71.4 60.9 35.7 87.5 63.33
Larger diameter (μm) 12.8 71.4 69.6 41.7 88.9 70.00
SD smaller diameter (μm) 2.0 85.7 69.6 46.2 94.1 73.33
PPV: Positive Predictive Value
NPV: Negative Predictive Value
SD: Standard Deviation
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Table 4　 Independent t test demonstrating the signiﬁcance of various parameters for the event of 
death to occur
Died N Mean t Sig. (2-tailed)
1．Invasive front grading (IFG)
Dead  7 12.086
1.054 0.301
Alive 23 10.983
2．Tumor size
Dead  7 3.571
1.498 0.145
Alive 23 3.044
3．Node
Dead  7 1.571
1.690 0.102
Alive 23 1.044
4．Metastasis
Dead  7 0.000
－0.545 0.590
Alive 23 0.044
5．Mitotic activity index (MAI)
Dead  7 12.286
1.738 0.093
Alive 23 7.739
6．Volume-corrected mitotic index (M/V)
Dead  7 2.462
2.605 0.015
Alive 23 1.250
7．Nuclear area (μm2)
Dead  7 113.307
2.341 0.027
Alive 23 84.201
8．SD Nuclear area (μm2)
Dead  7 40.483
3.177 0.004
Alive 23 26.814
9．Perimeter (μm)
Dead  7 569.270
2.601 0.015
Alive 23 423.461
10．SD Perimeter(μm)
Dead  7 203.408
2.756 0.010
Alive 23 135.339
11．Shape factor
Dead  7 0.530
－2.491 0.019
Alive 23 0.719
12．SD Shape factor
Dead  7 0.204
－1.911 0.066
Alive 23 0.317
13．Nuclear size
Dead  7 11.712
2.297 0.029
Alive 23 10.106
14．SD Nuclear size
Dead  7 2.053
2.395 0.024
Alive 23 1.632
15．Larger diameter (μm)
Dead  7 14.383
2.555 0.016
Alive 23 12.426
16．SD Larger diameter (μm)
Dead  7 2.688
1.550 0.132
Alive 23 2.251
17．Smaller diameter (μm)
Dead  7 9.703
1.718 0.097
Alive 23 8.421
18．SD Smaller diameter (μm)
Dead  7 2.297
2.704 0.012
Alive 23 1.877
19．Nuclear cytoplasmic ratio
Dead  7 0.910
－0.221 0.826
Alive 23 0.972
20．SD Nuclear cytoplasmic ratio
Dead  7 0.896
－0.311 0.758
Alive 23 1.380
21．Nucleolar nuclear ratio
Dead  7 0.105
－0.577 0.569
Alive 23 0.111
22．SD Nucleolar nuclear ratio
Dead  7 0.059
－0.128 0.899
Alive 23 0.061
SD: Standard Deviation
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ious sites, but the studies cannot be compared due 
to various methodological and biological factors. 
Haapasalo et al. (1989)6 introduced the volume-
corrected mitotic index (M/V index) to reduce this 
variability, and the technique has been reported to 
be a valuable tool in carcinoma of the ovaries, 
bladder, pancreas, breast and colon.  Our present 
study showed that the M/V index is a better pre-
dictive tool for recurrence than mitotic activity 
index with an efﬁciency of 86.67%.  Compared to 
other standard prognostic tools, the M/V index 
was proved by discriminant analysis to be supe-
rior (Table 5).
　The rationale behind this signiﬁcantly better 
performance of the M/V index may be as follows.
　1. The M/V index calculates the mitotic activity 
in the tumor proper, thus giving an accurate 
mitotic load of the tumor.  The actual tumor load 
is calculated by assessing the volume fraction of 
the tumor based on Delesse's principle which 
Table 5　 Coefﬁcients of Cox's regression analysis of the most im-
portant prognosticators (forward stepwise regression)
Feature Coefﬁcient Standard error
Volume-corrected mitotic 
index (M/V)
0.147 0.053
Standard deviation of
nuclear area (SDNA)
1.816 × 10－2 0.006
(constant) －(0.537) 0.189
Table 6　 Three-year survival rate with respect to different parameters based on univariate 
analysis
Parameter Cut-off
Number
 (n)
Mean survival time 
(in months)
Log rank test
χ2 P value
1. Volume-corrected
    mitotic index (M/V)
≤ 1.5 19 63
4.46 0.0347
> 1.5 11 23
2. Nuclear area
<80 13 66
3.33 0.0679
>80 17 33
3. SD Nuclear area
<30 17 63
3.39 0.0657
>30 13 26
4. Perimeter
<438 15 66
5.02 0.025
>438 15 31
5. SD Perimeter
<150 18 64
4.38 0.0363
>150 12 25
6. Shape factor
>0.65 17 67
7.44 0.0064
<0.65 13 28
7. Nuclear size
<10 17 66
3.33 0.0679
>10 13 33
8. SD Nuclear size
<1.7 16 44
2.59 0.1077
>1.7 14 46
9. Larger diameter
<12.8 18 64
4.38 0.0363
>12.8 12 25
10. SD Smaller diameter
<2.0 17 66
6.94 0.0084
>2.0 13 22
11. PIdeath
<0.4 21 67
17.46 0.00001
≥0.4  9 16
SD: Standard Deviation
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states that “in a rock composed of a number of 
minerals the area occupied by any given mineral 
on a surface of a section of the rock is proportional 
to the volume of the mineral in the rock.” This 
means that the volume of mineral can be assessed 
by calculating the area fraction in a cross-section. 
Weibel (1980)8 provided the mathematical proof of 
Delesse's principle in histological sections.  Thus, 
the area fraction of the tumor is given as a set of 
random ﬁelds correlated with the true tumor load.
　2. The M/V index accounts for the tumor pat-
tern.  The value of the index increases when a 
tumor is invading in smaller groups and vice 
versa, whereas the MAI remains constant as it 
does not include the fraction of neoplastic tissue.
　3. The use of a 1000-point grid eliminates the 
variability of size of the ﬁeld area for all micro-
scopes (regardless of the manufacturer and 
model), thus making the index standardized and 
comparable across various study groups.
　4. Assessment of M/V index at the invasive 
tumor front (ITF).  Most tumors consist of a het-
erogeneous cell population with variable biological 
behavior.  Tumor behavior is dependent on com-
plex interrelationships between tumor and host. 
Evidence suggests that cells present at the ITF of 
a carcinoma have different molecular characteris-
tics from those in superﬁcial areas of tumor9. 
Thus, the M/V index assessed at ITF makes the 
index a superior prognostic tool.
　Bryne et al. (1989)7 ﬁrst described a multiple 
histologic grading system for the ITF in head and 
neck tumors, based on the pattern of invasion, 
degree of keratinization, nuclear pleomorphism 
and host response.  They reported a strong correla-
tion between total malignancy grade and prognosis 
of glottic carcinoma.  Kurokawa et al. (2005)10 
observed a strong correlation between invasive 
Fig. 1　Survival functions (Kaplan-Meier curves) of prog-
nostic indicator of death with a cut-off of 0.4. Sur-
vival is signiﬁcantly increased in individuals with 
values below 0.4.
Fig. 2　 Survival functions (Kaplan-Meier curves) of 
volume-corrected mitotic index with a cut-off of 
1.5. Survival is significantly increased in 
individuals with values below 1.5.
Fig. 3　 Survival functions (Kaplan-Meier curves) of 
standard deviation of nuclear area with a cut-off 
of 30 square microns. Survival is signiﬁcantly 
increased in individuals with values below 30 
square microns.
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tumor front grading and prognosis of tongue 
squamous cell carcinoma.  The present study also 
analyzed the prognostic value of the histological 
grade of malignancy in the deep invasive tumor 
front of oral squamous cell carcinoma and it was 
seen that values of < 10 signiﬁcantly (p = 0.008) 
showed a reduced rate of local relapse (Table 2).
　Nuclear polymorphisms, which refer to varia-
tions in nuclear size, shape and hyperchromatism 
due to an increased DNA content and chromatin 
condensation in interphase nuclei, are a widely-
used criterion to recognize dysplastic and neoplas-
tic changes of mucosal epithelium.  Nuclear size 
corresponds to its DNA content and the amount of 
histone proteins, organic and inorganic material 
and water.  Numerous studies have shown a pro-
gressive increase in nuclear area in the process of 
transformation from normal or metaplastic 
mucosa to dysplasia to carcinoma3, 11.
　In the present study, the prognostic relevance of 
these nuclear alterations was substantiated and 
quantiﬁed.  The current data shows that discrimi-
nation between short-term and long-term survival 
is possible with morphometry and that the appli-
cation of this technique adds to the qualitative 
evaluation.  Nuclear area, perimeter, nuclear size 
and larger diameter were signiﬁcantly larger in 
the short-term survivors (Table 4).
　In long-term survivors the neoplastic nuclei are 
signiﬁcantly more circular i.e. less ellipsoid/spin-
dled than those in short-term survivors.  Nuclear 
shape factor and perimeter, indicators of regular-
ity of nuclear boundary, were powerful discrimina-
tors.  The nuclei in the group with a favorable 
prognosis had regular proﬁles (Table 4).  Our 
study supports the ﬁndings of Sutton et al. (2003)12 
who have shown that tumor cells with greater 
diameter tend to exhibit more aggressive patterns 
of invasion.
　The standard deviations of various stereological 
parameters are indicative of variation from the 
mean value and thus may be an objective reﬂec-
tion of pleomorphism.  In our study, the standard 
deviations of nuclear area, perimeter, shape factor 
and smaller diameter of nucleus were signiﬁcantly 
different among the two groups of subjects i.e., 
those with favorable prognosis and those with 
poor prognosis (Table 4).  These parameters indi-
cate that the tumor cells have already reached a 
stage in their evolution where they exhibit molec-
ular events that permit metastasis, such as the 
expression of cellular receptors and production of 
enzymes to facilitate their access to lymphatic 
vessels.  All these factors collectively may account 
for the reduced survival rate13.  The nuclear mor-
phometry of malignant tumors can thus reveal 
features that may otherwise escape the subjective 
analysis of cellular morphology.  Nuclear mor-
phometry can aid in the accurate diagnosis and 
grading of oral squamous cell carcinoma.  The 
combination of morphometric parameters may 
shed light on the hidden implications of numerical 
values obtained by discriminant analysis, where 
the standard deviation of nuclear area and M/V 
index were combined (PIdeath ; p = 0.00001 and χ2 = 
17.46).  This could be histopathologically corre-
lated with the variation of nuclear area (SD 
nuclear area) and proliferative load (M/V index) 
being the best prognosticators.
　In the present study, clinically, the size of tumor 
(T) and regional lymph node (N) did not signiﬁ-
cantly correlate with M/V index (Table 4).  In early 
cancer cases (T2) the recurrence rate was higher in 
patients with higher M/V index.  Similarly, in 
patients with N0 cancer, those with a high M/V 
index had a higher recurrence rate than those 
with a low M/V index.  Imai et al.1 in their study 
found that M/V index and DNA ploidy showed 
similar prognostic results for predicting the out-
come of oral cancer.  Thus, the M/V index appears 
to be a better independent prognostic factor. 
Tumor control is difﬁcult even in the early stages 
in patients with a high M/V index.  Thus, patients 
with high M/V values should be recalled for clini-
cal assessment more frequently.  The results of the 
present study emphasize the applicability of the M/
V index as a prognostic indicator of oral squamous 
cell carcinoma.  Additionally, since measurement of 
M/V index was performed without difﬁculty in rou-
tine hematoxylin and eosin sections and took 
approximately 15 minutes per case, we strongly 
advocate the inclusion of M/V index as a prognostic 
indicator in oral cancer.  Aggressive treatment pro-
tocols should be followed up in the initial and fol-
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low-up treatment of oral cancer patients with high 
M/V index values.
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